Register   |   Log In Contact Us
Or login with one of the following

Log in

 

Prostate Cancer

Development and clinical validation of an in situ biopsy based multi-marker assay for risk stratification in prostate cancer - Abstract

Purpose: Prostate cancer aggressiveness and appropriate therapy are routinely determined following biopsy sampling.

Read more ...

Pudendal nerve injury in men with fecal incontinence after radiotherapy for prostate cancer - Abstract

Background: The precise etiology of fecal incontinence (FI), which occurs frequently following external beam radiotherapy (EBRT) for prostate carcinoma is unknown.

Read more ...

The utility and limitations of contrast-enhanced ultrasound for the diagnosis and treatment of prostate cancer - Abstract

In association with the widespread use of prostate specific antigen (PSA) screening, the numbers of men identified with early-stage prostate cancer (PCa) are increasing in the developed countries, including Japan.

Read more ...

Management of biochemically recurrent prostate cancer following local therapy - Abstract

Localized therapy for prostate cancer is often curative; however, 20% to 30% of patients experience a recurrence.

Read more ...

Managing advanced prostate cancer: The rapidly changing treatment landscape - Abstract

The FDA approval of 5 new therapeutic agents within a 4-year time frame, all of which potentially improve survival for patients with metastatic castration-resistant prostate cancer, is unprecedented in oncology.

Read more ...

Is there any change in pelvic floor electromyography during the first 6 months after radical retropubic prostatectomy? - Abstract

The aim of this study is to determine electromyographic pelvic floor muscles activity during the first 6 months post RRP and its relationship to urinary continence.

Read more ...

High-dose-rate brachytherapy as a monotherapy for prostate cancer-Single-institution results of the extreme fractionation regimen - Abstract

PURPOSE: We report a single-institution retrospective analysis of the outcomes, disease control, and toxicity of high-dose-rate (HDR) brachytherapy used as the only treatment modality (monotherapy) for localized prostate cancer.

Read more ...

Changing trends in surgical management of prostate cancer: The end of overtreatment? - Abstract

The use of prostate-specific antigen (PSA) for screening or early detection of prostate cancer (PCa) results in significant stage migration toward more favorable stages and a proven decrease in PCa mortality but is accompanied by substantial rates of overdiagnosis and over-treatment.

Read more ...

Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer - Abstract

BACKGROUND: Physicians managing patients with prostate cancer play a critical role in subsequent specialist consultations and initial treatment choice, especially in cases for which no consensus exists regarding optimal treatment strategy.

Read more ...

Geographic disparities in prostate cancer outcomes - review of international patterns - Abstract

BACKGROUND: This study reviewed the published evidence as to how prostate cancer outcomes vary across geographical remoteness and area level disadvantage.

Read more ...